Leveraging immune memory against measles virus as an antitumor strategy in a preclinical model of aggressive squamous cell carcinoma

• Markus Steiner,
• Richard Greil,
• Victoria M Leb-Reichl,
• Melanie Kienzl,
• Anna Kaufmann,
• Angelika Stoecklinger,
• Birgit Tockner,
• Sophie Kitzmueller,
• Nadja Zaborsky,
• Gabriele Brachtl,
• Lisa Trattner,
• Patrick Kreideweiss,
• Christian Reinsch,
• Steffen Panzner,
• Dirk Strunk,
• Johann W Bauer,
• Iris K Gratz,
• Christina Guttmann-Gruber,
• Josefina Piñón Hofbauer

Affiliations

Markus Steiner

School of Medicine, Department of Child Health, University of Aberdeen, Aberdeen, UK

Richard Greil

6IIIrd Medical Department, Paracelsus Me, Salzburg, Austria

Victoria M Leb-Reichl

EB House Austria, Research Program for Molecular Therapy of Genodermatoses, Department of Dermatology and Allergology, University Hospital of the Paracelsus Medical University Salzburg, Salzburg, Austria

Melanie Kienzl

EB House Austria, Research Program for Molecular Therapy of Genodermatoses, Department of Dermatology and Allergology, University Hospital of the Paracelsus Medical University Salzburg, Salzburg, Austria

Anna Kaufmann

EB House Austria, Research Program for Molecular Therapy of Genodermatoses, Department of Dermatology and Allergology, University Hospital of the Paracelsus Medical University Salzburg, Salzburg, Austria

Angelika Stoecklinger

Department of Biosciences, University of Salzburg, Salzburg, Austria

Birgit Tockner

EB House Austria, Research Program for Molecular Therapy of Genodermatoses, Department of Dermatology and Allergology, University Hospital of the Paracelsus Medical University Salzburg, Salzburg, Austria

Sophie Kitzmueller

EB House Austria, Research Program for Molecular Therapy of Genodermatoses, Department of Dermatology and Allergology, University Hospital of the Paracelsus Medical University Salzburg, Salzburg, Austria

Nadja Zaborsky

Salzburg Cancer Research Institute—Laboratory for Immunological and Molecular Cancer Research, University Hospital of the Paracelsus Medical University Salzburg, Salzburg, Austria

Gabriele Brachtl

Experimental and Clinical Cell Therapy Institute, Spinal Cord Injury & Tissue Regeneration Center, Paracelsus Medical University Salzburg, Salzburg, Austria

Lisa Trattner

EB House Austria, Research Program for Molecular Therapy of Genodermatoses, Department of Dermatology and Allergology, University Hospital of the Paracelsus Medical University Salzburg, Salzburg, Austria

Patrick Kreideweiss

Lipocalyx GmbH, Halle, Germany

Christian Reinsch

Lipocalyx GmbH, Halle, Germany

Steffen Panzner

Lipocalyx GmbH, Halle, Germany

Dirk Strunk

Experimental and Clinical Cell Therapy Institute, Spinal Cord Injury & Tissue Regeneration Center, Paracelsus Medical University Salzburg, Salzburg, Austria

Johann W Bauer

EB House Austria, Research Program for Molecular Therapy of Genodermatoses, Department of Dermatology and Allergology, University Hospital of the Paracelsus Medical University Salzburg, Salzburg, Austria

Iris K Gratz

EB House Austria, Research Program for Molecular Therapy of Genodermatoses, Department of Dermatology and Allergology, University Hospital of the Paracelsus Medical University Salzburg, Salzburg, Austria

Christina Guttmann-Gruber

EB House Austria, Research Program for Molecular Therapy of Genodermatoses, Department of Dermatology and Allergology, University Hospital of the Paracelsus Medical University Salzburg, Salzburg, Austria

Josefina Piñón Hofbauer

EB House Austria, Research Program for Molecular Therapy of Genodermatoses, Department of Dermatology and Allergology, University Hospital of the Paracelsus Medical University Salzburg, Salzburg, Austria